PL2146209T3 - Neurodegeneratywne markery choroby Alzheimera - Google Patents

Neurodegeneratywne markery choroby Alzheimera

Info

Publication number
PL2146209T3
PL2146209T3 PL09013088T PL09013088T PL2146209T3 PL 2146209 T3 PL2146209 T3 PL 2146209T3 PL 09013088 T PL09013088 T PL 09013088T PL 09013088 T PL09013088 T PL 09013088T PL 2146209 T3 PL2146209 T3 PL 2146209T3
Authority
PL
Poland
Prior art keywords
disease
alzheimer
markers
neurodegenerative
values
Prior art date
Application number
PL09013088T
Other languages
English (en)
Inventor
Aye Mu Myint
Manfred Schawaller
Markus J Schwarz
Harald Hampel
Original Assignee
Univ Of Antwerp
Univ Of Maastricht
Klinik Und Poliklinik Fuer Psychiatrie Und Psychotherapie
Verstappen Leopold
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Of Antwerp, Univ Of Maastricht, Klinik Und Poliklinik Fuer Psychiatrie Und Psychotherapie, Verstappen Leopold filed Critical Univ Of Antwerp
Publication of PL2146209T3 publication Critical patent/PL2146209T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G01N33/942—Serotonin, i.e. 5-hydroxy-tryptamine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Mushroom Cultivation (AREA)
  • Input From Keyboards Or The Like (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
PL09013088T 2005-04-06 2006-03-30 Neurodegeneratywne markery choroby Alzheimera PL2146209T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05007558 2005-04-06
EP09013088A EP2146209B1 (en) 2005-04-06 2006-03-30 Neurodegenerative markers for Alzheimer's disease
EP06723873A EP1866650B1 (en) 2005-04-06 2006-03-30 Neurodegenerative markers for depression.

Publications (1)

Publication Number Publication Date
PL2146209T3 true PL2146209T3 (pl) 2012-05-31

Family

ID=36293430

Family Applications (2)

Application Number Title Priority Date Filing Date
PL09013088T PL2146209T3 (pl) 2005-04-06 2006-03-30 Neurodegeneratywne markery choroby Alzheimera
PL06723873T PL1866650T3 (pl) 2005-04-06 2006-03-30 Neurodegeneracyjne markery depresji

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL06723873T PL1866650T3 (pl) 2005-04-06 2006-03-30 Neurodegeneracyjne markery depresji

Country Status (14)

Country Link
US (2) US20080131921A1 (pl)
EP (2) EP2146209B1 (pl)
JP (1) JP4958893B2 (pl)
AT (2) ATE534038T1 (pl)
CY (1) CY1110116T1 (pl)
DE (1) DE602006014379D1 (pl)
DK (2) DK2146209T3 (pl)
ES (2) ES2377704T3 (pl)
HK (1) HK1137219A1 (pl)
NO (2) NO20075671L (pl)
PL (2) PL2146209T3 (pl)
PT (2) PT2146209E (pl)
SI (1) SI1866650T1 (pl)
WO (1) WO2006105907A1 (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2053405A4 (en) * 2006-08-04 2009-11-11 Ajinomoto Kk METHOD FOR EVALUATING STRESS, STRESS EVALUATION DEVICE, STRESS EVALUATION METHOD, STRESS EVALUATION SYSTEM, STRESS EVALUATION PROGRAM AND RECORDING MEDIUM
AT9843U1 (de) * 2007-03-27 2008-04-15 Kepplinger Berthold Dr Messung von biologischen markern
AU2009205956B2 (en) 2008-01-18 2015-07-02 President And Fellows Of Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
WO2009096502A1 (ja) * 2008-01-31 2009-08-06 Japan As Represented By President Of National Center Of Neurology And Psychiatry うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断
WO2009100243A2 (en) * 2008-02-05 2009-08-13 University Of Miami Elavl4 as a predictor of depression in alzheimer's disease and parkinson's disease patients
CN102667485B (zh) 2009-08-12 2015-04-22 福满代谢组技术有限公司 抑郁症的生物标记物、抑郁症的生物标记物的测定方法、计算机程序及记录介质
MX361944B (es) 2010-07-23 2018-12-19 President And Fellows Of Harvard College Star Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales.
EP2596353A4 (en) 2010-07-23 2014-01-15 Harvard College METHOD FOR DETECTING PRENATAL OR PREGNANT DISEASES OR SUFFERING
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
SG10201505724SA (en) 2010-07-23 2015-09-29 Harvard College Methods of detecting diseases or conditions using phagocytic cells
WO2013069645A1 (ja) 2011-11-10 2013-05-16 ヒューマン・メタボローム・テクノロジーズ株式会社 エタノールアミンリン酸の測定方法
AU2013274002A1 (en) 2012-06-15 2015-02-05 Harry Stylli Methods of detecting diseases or conditions
KR20150035818A (ko) 2012-06-15 2015-04-07 해리 스타일리 순환 병든 세포를 사용하여 질환 또는 병태를 검출하는 방법
WO2014068144A1 (en) 2012-11-05 2014-05-08 Ospedale San Raffaele S.R.L. Biomarkers of multiple myeloma development and progression
EP2965086A4 (en) 2013-03-09 2017-02-08 Harry Stylli Methods of detecting prostate cancer
US10494675B2 (en) 2013-03-09 2019-12-03 Cell Mdx, Llc Methods of detecting cancer
EP2799878A1 (en) * 2013-05-03 2014-11-05 SALION GmbH In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant using kynurenine as a marker.
US20160003857A1 (en) * 2014-07-02 2016-01-07 Cecil Bennett Methods and systems for detecting polypharmacy
WO2016040843A1 (en) 2014-09-11 2016-03-17 Harry Stylli Methods of detecting prostate cancer
US11806385B2 (en) 2016-04-22 2023-11-07 Board Of Regents Of The University Of Nebraska Biomarkers for monitoring immune transformation
EP3413050A1 (en) * 2017-06-08 2018-12-12 SALION GmbH In vitro method for the determination of neurodegenerative diseases
EP3688186A4 (en) * 2017-09-27 2021-10-13 University of North Carolina Wilmington HUMAN SEWAGE AND HUMAN-DERIVED PATHOGEN SEARCH TOOL
WO2019181830A1 (ja) 2018-03-19 2019-09-26 富士フイルム和光純薬株式会社 精神疾患の判定方法
CA3094504A1 (en) * 2018-03-22 2019-09-26 Japan Medical Device Technology Co., Ltd. Bioabsorbable stent
KR102159344B1 (ko) * 2019-08-05 2020-09-23 한국과학기술연구원 행위 중독의 진단용 조성물, 키트 및 이를 이용한 행위 중독의 진단을 위한 키누레닌의 검출 방법
JP7389139B2 (ja) * 2019-11-26 2023-11-29 京セラ株式会社 ストレス計測システムおよびストレス計測方法
JP2023549028A (ja) * 2020-10-06 2023-11-22 学校法人沖縄科学技術大学院大学学園 アルツハイマー病（ａｄ）の診断のための指標を得るための方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194217B1 (en) * 1980-01-14 2001-02-27 Esa, Inc. Method of diagnosing or categorizing disorders from biochemical profiles
JP2000131318A (ja) * 1998-10-22 2000-05-12 Nikken Foods Co Ltd 快・不快ストレス状態解析方法
EP1050758A1 (en) * 1999-05-03 2000-11-08 Evotec BioSystems AG Methods of diagnosing or treating neuropsychiatric diseases on basis of increased cerebrospinal fluid levels of neurotrophin 3
FR2827045B1 (fr) * 2001-07-05 2007-08-10 Univ Pasteur Methodes et compositions pour la selection et le developpement de nouveaux agents pharmacologiques ou de nouveaux medicaments
JP2004198325A (ja) * 2002-12-19 2004-07-15 Oriental Yeast Co Ltd ストレスの測定方法

Also Published As

Publication number Publication date
EP2146209A1 (en) 2010-01-20
DE602006014379D1 (de) 2010-07-01
CY1110116T1 (el) 2015-01-14
ATE468537T1 (de) 2010-06-15
PT1866650E (pt) 2010-06-01
SI1866650T1 (sl) 2010-12-31
PL1866650T3 (pl) 2011-04-29
US20080131921A1 (en) 2008-06-05
ES2346467T3 (es) 2010-10-15
EP2146209B1 (en) 2011-11-16
DK2146209T3 (da) 2012-02-13
JP4958893B2 (ja) 2012-06-20
EP1866650A1 (en) 2007-12-19
DK1866650T3 (da) 2010-09-06
ATE534038T1 (de) 2011-12-15
NO20075671L (no) 2007-11-06
NO20120452L (no) 2007-11-06
JP2008537111A (ja) 2008-09-11
WO2006105907A1 (en) 2006-10-12
HK1137219A1 (en) 2010-07-23
ES2377704T3 (es) 2012-03-30
PT2146209E (pt) 2011-12-30
EP1866650B1 (en) 2010-05-19
US20120196300A1 (en) 2012-08-02

Similar Documents

Publication Publication Date Title
HK1137219A1 (en) Neurodegenerative markers for alzheimer's disease
WO2006134390A3 (en) Method for diagnosing neurodegenerative disease
MX2007016136A (es) Metodo para diagnosticar la enfermedad de alzheimer.
WO2005047484A3 (en) Biomarkers for alzheimer's disease
HK1128684A1 (en) Isotopically-labeled benzofuran compounds as imagingagents foramyloidogenic proteins
IL170574A (en) Method for measuring force-dependent gyroscope sensitivity
IL211540A0 (en) Optical method for the detection of alzheimer's disease
WO2006090389A3 (en) Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
EP1700096A4 (en) PROOF OF PROTEINS AND PRIONS WITH CHANGED CONFORMATION
IL195288A0 (en) Procedure and methods for detecting alzheimer's disease
WO2007106762A3 (en) Alzheimer's disease biomarkers and methods of use
EP1855525A4 (en) FISH MODELS ZEBRA OF ALZHEIMER'S DISEASE
AU2010202926B2 (en) Markers and methods relating to the assessment of Alzheimer's disease
FR2874675B1 (fr) Frein pour roue avec capteur d'usure
AU2374302A (en) Means for detecting pathological transformation of the app protein and their uses
ZA200603178B (en) Quick test for the diagnosis of Alzheimer's disease
EP1604613A4 (en) CATHETER SENSOR FOR MEASURING HARDNESS
WO2010043393A8 (en) Use of biglycan in the assessment of heart failure
ATE414904T1 (de) Verfahren zum testen des oxidiertes-ldl-beta-2- glycoprotein-i-komplexes in vivo
DK1639139T3 (da) Fremgangsmåder til påvisning af Alzheimers sygdom
GB0622194D0 (en) Method for diagnosing or detecting alzheimer's disease
FR2852096B1 (fr) Instrument indicateur de direction permettant d'indiquer l'heure et la direction de la mecque.
HK1110388A1 (en) Fragment of neurosecretory protein vgf as a biomarker for alzheimer's disease
GB0506410D0 (en) Apparatus for indicating a person's driving ability
GB0517317D0 (en) Alex's cycle indicator